SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2.35 |
Enterprise Value ($M) | 0.48 |
Book Value ($M) | -2.79 |
Book Value / Share | -0.57 |
Price / Book | -0.84 |
NCAV ($M) | -2.79 |
NCAV / Share | -0.57 |
Price / NCAV | -0.84 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -1.32 |
Return on Equity (ROE) | -2.65 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.48 |
Current Ratio | 0.48 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.59 |
Assets | 2.59 |
Liabilities | 5.39 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Intracoastal Capital, Llc | 4.99 | ||
13G/A | Sabby Management, Llc | 0.00 | -100.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,863 | 36,934 | 7.75 | |
1,339 | 94,699 | 1.41 | |
26,505 | 408,431 | 6.49 | |
1,318 | 19,562 | 6.74 | |
(click for more detail) |
Similar Companies | |
---|---|
VINC – Vincerx Pharma, Inc. | VIRX – Viracta Therapeutics, Inc. |
VKTX – Viking Therapeutics, Inc. | VSTM – Verastem, Inc. |
VTGN – Vistagen Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io